Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Companies don’t generally cut prices out of generosity. For most of Big Pharma, drug discounts have largely been about damage control. After months of tariff threats and talk of tougher pricing rules ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

Food and Drug Administration Commissioner Marty Makary said in September he was changing leucovorin’s label because it could help “hundreds of thousands” of children with the neurological condition.

Name brand GLP-1 drugs like Ozempic and Wegovy have quickly become household names, akin to Tylenol or Advil, and their rise in popularity is only increasing. Originally developed to treat Type 2 ...

This article first appeared in the newsletter Your Local Epidemiologist. Pharmaceutical ads in the United States are annoying. Absurd. And almost uniquely American. In fact, only one other high-income ...

Investigation raises concerns about lack of FDA quality testing for generic drugs By some estimates, about 90% of prescriptions in the U.S. are filled with generic drugs. The Food and Drug ...

Black box warnings, or boxed warnings, are serious warnings that come from the FDA. They are meant to alert people about drug effects that may be dangerous. Specific drugs may carry a boxed warning, ...